EndoChoice Holdings, Inc.
Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY15 | FY14 | FY13 | |
|---|---|---|---|
| Revenue | $16.7M | $13.8M | $50.9M |
| Operating income | −$12.5M | −$10.1M | −$25.7M |
| Net income | −$15.3M | −$10.9M | −$23.9M |
| Total assets | $164.3M | $86.8M | — |
| Total liabilities | $65.0M | $60.6M | — |
| Equity | $99.3M | −$99.2M | −$40.5M |
| EPS (diluted) | — | — | — |
| Shares out. | 24.9M | 0 | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2015- Operating margin
- −74.3%
- Net margin
- −91.2%
- Return on equity
- −15.4%
- Return on assets
- −9.3%
- Return on capital (ROCE)
- −8.5%
- Liabilities / assets
- 39.6%
- Debt / equity
- 0.66×
- Book value / share
- $3.99
- Revenue growth (YoY)
- 21.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2015- Altman Z″ (distress)
- 1.17grey zone
- Accruals / assets
- 16.6%high accruals
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 5 warning● 2 good- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- High accruals — earnings-quality risk
- Altman Z″ in the grey zone
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Change in control · Director / officer change · Amended charter or bylawsNov 22, 2016
- Entered a material agreement · Regulation FD disclosureSep 27, 2016
- Results of operationsAug 4, 2016
- Director / officer change · Shareholder voteMay 4, 2016
- Results of operationsMay 4, 2016
- Results of operations · Director / officer changeMar 3, 2016
- Results of operationsJan 8, 2016
- Regulation FD disclosureNov 5, 2015
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 14, 2017
- SC 13G/ASCHEDULE 13G [AMENDMENT NO.1]Feb 10, 2017
- SC 13G/AFeb 2, 2017
- SC 13D/ADec 21, 2016
- 15-12BDec 5, 2016
- SC 13D/ANov 28, 2016
- 4FORM 4Nov 23, 2016
- 4FORM 4Nov 23, 2016
- 4FORM 4Nov 23, 2016
- 4FORM 4Nov 23, 2016
- 4FORM 4Nov 23, 2016
- 4FORM 4Nov 23, 2016
- 4FORM 4Nov 23, 2016
- 4FORM 4Nov 23, 2016
- 4FORM 4Nov 23, 2016